Truffi, M.; Sottotetti, F.; Gafni, N.; Albasini, S.; Piccotti, F.; Morasso, C.; Tibollo, V.; Mocchi, M.; Zanella, V.; Corsi, F.
Prognostic Potential of Immune Inflammatory Biomarkers in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Cancers 2022, 14, 5287.
https://doi.org/10.3390/cancers14215287
AMA Style
Truffi M, Sottotetti F, Gafni N, Albasini S, Piccotti F, Morasso C, Tibollo V, Mocchi M, Zanella V, Corsi F.
Prognostic Potential of Immune Inflammatory Biomarkers in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Cancers. 2022; 14(21):5287.
https://doi.org/10.3390/cancers14215287
Chicago/Turabian Style
Truffi, Marta, Federico Sottotetti, Nadav Gafni, Sara Albasini, Francesca Piccotti, Carlo Morasso, Valentina Tibollo, Michela Mocchi, Valentina Zanella, and Fabio Corsi.
2022. "Prognostic Potential of Immune Inflammatory Biomarkers in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy" Cancers 14, no. 21: 5287.
https://doi.org/10.3390/cancers14215287
APA Style
Truffi, M., Sottotetti, F., Gafni, N., Albasini, S., Piccotti, F., Morasso, C., Tibollo, V., Mocchi, M., Zanella, V., & Corsi, F.
(2022). Prognostic Potential of Immune Inflammatory Biomarkers in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Cancers, 14(21), 5287.
https://doi.org/10.3390/cancers14215287